Cyclosporine, tacrolimus, and mycophenolate mofetil in the treatment of inflammatory bowel disease-Reference-Cited by-同舟云学术

Cyclosporine, tacrolimus, and mycophenolate mofetil in the treatment of inflammatory bowel disease

Published:2004-06 Issue:2 Volume:33 Page:141-169
ISSN:0889-8553
Container-title:Gastroenterology Clinics of North America
language:en
Short-container-title:Gastroenterology Clinics of North America

Author:

Loftus Conor G,Egan Laurence J,Sandborn William J

Publisher

Elsevier BV

Subject

Gastroenterology

Reference154 articles.

1. Inflammatory bowel disease;Podolsky;N Engl J Med,2002

2. Effect of cyclosporin A on human lymphocyte responses in vitro III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF;Hess;J Immunol,1982

3. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes;Liu;Cell,1991

4. Regulation of gene expression in lectin-stimulated or lymphokine-stimulated T lymphocytes: effects of cyclosporine;Reed;Transplantation,1988

5. Cyclosporine;Kahan;N Engl J Med,1989

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pregnancy and medications for inflammatory bowel disease: An updated narrative review;World Journal of Clinical Cases;2023-03-16

2. An Old Bridge to the Newer Biologics: Cyclosporine for Rescue Therapy in Acute Severe Ulcerative Colitis;Digestive Diseases and Sciences;2022-09-20

3. An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis;Journal of Clinical Medicine;2022-04-20

4. Nonbiological therapeutic management of ulcerative colitis;Expert Opinion on Pharmacotherapy;2018-09-27

5. The safety of non-biological treatments in Ulcerative Colitis;Expert Opinion on Drug Safety;2017-06-19